Abstract:Extracellular vesicles (EVs) function as a mode of intercellular communication and molecular transfer to elicit diverse biological/functional response. Accumulating evidence has highlighted that EVs from immune, tumour, stromal cells and even bacteria and parasites mediate the communication of various immune cell types to dynamically regulate host immune response. EVs have an innate capacity to evade recognition, transport and transfer functional components to target cells, with subsequent removal by the immune system, where the immunological activities of EVs impact immunoregulation including modulation of antigen presentation and cross-dressing, immune activation, immune suppression, and immune surveillance, impacting the tumour immune microenvironment. In this review, we outline the recent progress of EVs in immunorecognition and therapeutic intervention in cancer, including vaccine and targeted drug delivery and summarise their utility towards clinical translation. We highlight the strategies where EVs (natural and engineered) are being employed as a therapeutic approach for immunogenicity, tumoricidal function, and vaccine development, termed immuno-EVs. With seminal studies providing significant progress in the sequential development of engineered EVs as therapeutic anti-tumour platforms, we now require direct assessment to tune and improve the efficacy of resulting immune responses - essential in their translation into the clinic. We believe such a review could strengthen our understanding of the progress in EV immunobiology and facilitate advances in engineering EVs for the development of novel EV-based immunotherapeutics as a platform for cancer treatment.

Engineered extracellular vesicles and their mimetics for cancer immunotherapy

Engineered Extracellular Vesicles for Cancer Therapy

Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy

Engineered extracellular vesicles: potentials in cancer combination therapy

Extracellular Vesicles-Based Drug Delivery Systems for Cancer Immunotherapy

Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance

Genetically engineered cell-derived nanovesicles for cancer immunotherapy

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Extracellular vesicles reshape the tumor microenvironment to improve cancer immunotherapy: Current knowledge and future prospects

Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy

Extracellular vesicles derived from immune cells: Role in tumor therapy

Extracellular vesicles as next generation immunotherapeutics

Engineered Extracellular Vesicles-Like Biomimetic Nanoparticles As an Emerging Platform for Targeted Cancer Therapy

Application of engineered extracellular vesicles for targeted tumor therapy

Engineering extracellular vesicles for cancer therapy: recent advances and challenges in clinical translation

New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies

Extracellular Vesicles in Cancer Therapy: Roles, Potential Application, and Challenges

Extracellular vesicles for cancer therapy: potential, progress, and clinical challenges

Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy

Extracellular Vesicles as Drug Delivery System for Cancer Therapy

Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy